Deal Watch
WHO urges US to ‘reconsider’ withdrawal from global health organisation
President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises
Honoring Educational Partners at ACG
The recent ACG conference was an opportunity for members of the Medscape team to shine a light on their educational partners and honor them for their exceptional work.On October 21,...
International NASH Day 2023
Shari Dermer, PhD of Medscape Education, hosted Michael Betel, Founder and President of Fatty Liver Alliance, in an engaging conversation around the importance of NASH awareness, diagnosis, and prognosis. Listen...
How the WHO hepatitis strategy measures up in the field
With hepatitis cases on the rise, Dr Anthony Martinez, member of the International Hepatitis Education Program (IHEP), shares his perspective on the World Health Organization’s new strategy for hepatitis elimination...
Future of MHRA uncertain amid Brexit-fuelled shake up
Trade unions and regulatory experts warn that budget and staff cuts may lead to drug approval delays or the UK regulator simply rubber-stamping EMA decisions
MHRA outlines two-year delivery plan with ‘patient first’ focus
New delivery plan also outlines strategy for UK regulatory body following Brexit
Gilead and Novo Nordisk boost NASH partnership with new mid-stage study
The two companies first announced their NASH collaboration in 2019
The Brexit clock is counting down and time is running out
What businesses need to know about post-Brexit immigration
Merck enters agreement with Hanmi for investigational NASH drug
Licensing agreement includes $10m upfront payment
Genfit scraps phase 3 trial of experimental NASH drug
Drug failed to meet primary endpoint in interim analysis
Zydus Cadila scores first ever NASH approval, in India
Drug has already been approved for diabetes related conditions